BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28038447)

  • 21. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
    Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
    Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
    Papadhimitriou SI; Terpos E; Liapis K; Pavlidis D; Marinakis T; Kastritis E; Dimopoulos MA; Tsitsilonis OE; Kostopoulos IV
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sizes and shapes of tumor cells in plasma cell leukemia and plasma cell myeloma.
    Isobe T; Ikeda Y; Ohta H
    Blood; 1979 May; 53(5):1028-30. PubMed ID: 435639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
    Jonveaux P; Berger R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
    Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
    Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N; Alnounou R; Alzahrani H; Alsharif F
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
    Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
    Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent upregulation of MYC in plasma cell leukemia.
    Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
    Bollati V; Fabris S; Pegoraro V; Ronchetti D; Mosca L; Deliliers GL; Motta V; Bertazzi PA; Baccarelli A; Neri A
    Carcinogenesis; 2009 Aug; 30(8):1330-5. PubMed ID: 19531770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
    Wang H; Zhou H; Zhang Z; Geng C; Chen W
    Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival.
    Champion O; Soler A; Maïga S; Bellanger C; Pellat-Deceunynck C; Talbot A; Touzeau C; Amiot M; Gomez-Bougie P
    Front Oncol; 2023; 13():1196005. PubMed ID: 37534243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple myeloma and secondary plasma cell leukemia.
    Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA
    Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.
    Mohamed A; Collins J; Jiang H; Molendijk J; Stoll T; Torta F; Wenk MR; Bird RJ; Marlton P; Mollee P; Markey KA; Hill MM
    PLoS One; 2020; 15(1):e0227455. PubMed ID: 31914155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cell leukemia.
    Hayman SR; Fonseca R
    Curr Treat Options Oncol; 2001 Jun; 2(3):205-16. PubMed ID: 12057120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iTRAQ analysis of a cell culture model for malignant transformation, including comparison with 2D-PAGE and SILAC.
    Pütz SM; Boehm AM; Stiewe T; Sickmann A
    J Proteome Res; 2012 Apr; 11(4):2140-53. PubMed ID: 22313033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.
    Heuck CJ; Mehta J; Bhagat T; Gundabolu K; Yu Y; Khan S; Chrysofakis G; Schinke C; Tariman J; Vickrey E; Pulliam N; Nischal S; Zhou L; Bhattacharyya S; Meagher R; Hu C; Maqbool S; Suzuki M; Parekh S; Reu F; Steidl U; Greally J; Verma A; Singhal SB
    J Immunol; 2013 Mar; 190(6):2966-75. PubMed ID: 23408834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global methylation patterns in primary plasma cell leukemia.
    Todoerti K; Calice G; Trino S; Simeon V; Lionetti M; Manzoni M; Fabris S; Barbieri M; Pompa A; Baldini L; Bollati V; Zoppoli P; Neri A; Musto P
    Leuk Res; 2018 Oct; 73():95-102. PubMed ID: 30257227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.